COVID-19 has become the global focus since December 2019[1]. Patients usually experience cough, fever and flu-like symptoms. Most patients also experience dyspnoea. Elevated procalcitonin, lymphopenia are observed in COVID-19 patients. Recently, a case series analysis has predicted that lymphopenia may be a very good prognostic marker for disease progression in COVID-19[2].